𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Practical guidelines for the community treatment of markedly impaired patients

✍ Scribed by Mary Ann Test; Leonard I. Stein

Publisher
Springer
Year
1976
Tongue
English
Weight
718 KB
Volume
12
Category
Article
ISSN
0010-3853

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

AASLD practice guidelines: Evaluation of
AASLD practice guidelines: Evaluation of the patient for liver transplantation
✍ Karen F. Murray; Robert L. Carithers Jr. πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 233 KB

These recommendations provide a data-supported approach. They are based on the following: (1) formal review and analysis of the recently published world literature on the topic [Medline search]; (2) American College of Physicians Manual for Assessing Health Practices and Designing Practice Guideline

Updated clinical practice guidelines for
Updated clinical practice guidelines for the prevention and treatment of mucositis
✍ Dorothy M. Keefe; Mark M. Schubert; Linda S. Elting; Stephen T. Sonis; Joel B. E πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 165 KB πŸ‘ 2 views

## Abstract Considerable progress in research and clinical application has been made since the original guidelines for managing mucositis in cancer patients were published in 2004, and the first active drug for the prevention and treatment of this condition has been approved by the United States Fo

Practical guidelines for the management
Practical guidelines for the management of interferon-Ξ±-2b side effects in patients receiving adjuvant treatment for melanoma : Expert opinion
✍ Axel Hauschild; Helen Gogas; Ahmad Tarhini; Mark R. Middleton; Alessandro Testor πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 177 KB

## Abstract Interferon‐α‐2b (IFNΞ±2b) is the only effective adjuvant therapy for melanoma patients at high risk of recurrence that has been approved by regulatory authorities worldwide. However, IFN toxicities increase the risk of poor treatment compliance and impair the potential for benefit from t

Applicability of teicoplanin dosage adju
Applicability of teicoplanin dosage adjustment guidelines for renally impaired patients over the range of 3 to 30MGKGβˆ’1
✍ Jacquelyn A. Smithers; Dr Gary A. Thompson; Michael T. Kenny; Jacqueline K. Dulw πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 504 KB

## Abstract The pharmacokinetics of teicoplanin were investigated in 13 subjects with various degrees of renal impairment using a randomized two‐period crossover design; 11 subjects completed both periods. Doses of 3 and 30 mg kg^βˆ’1^ were administered as single dose, 60‐min constant rate intravenou